Ethylenediamine

Ethylenediamine

SCHEMBL524897

C=C(C)C(N)=O.NCCN

nearest known ligand 0.75

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D

The experimentally established mechanism targets of Ethylenediamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.75
LMNA P02545 1/20 0.41
ALOX15 P16050 1/20 0.41
BLM P54132 1/20 0.41
PMP22 Q01453 1/20 0.41
PAOX Q6QHF9 3/20 0.36
ALDH1A1 P00352 3/20 0.35
THRB P10828 1/20 0.34
TSHR P16473 3/20 0.33
LDHA P00338 1/20 0.32
LDHB P07195 1/20 0.32
GABRR1 P24046 2/20 0.31
HSD17B10 Q99714 1/20 0.30
CRBN Q96SW2 1/20 0.30
GLRA1 P23415 1/20 0.30
SLC6A9 P48067 1/20 0.30
OR51E2 Q9H255 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylenediamine SCHEMBL8998818 1.00 TDP1 (0.75) TDP1LMNAALOX15BLMPMP22
Ethylenediamine SCHEMBL10644761 1.00 TDP1 (0.75) TDP1LMNAALOX15BLMPMP22
Ethylenediamine SCHEMBL8679720 0.97 TDP1 (0.71) TDP1LMNAALOX15BLMPMP22
SCHEMBL8190449 0.88 TDP1 (0.67) TDP1LMNAALOX15BLMPMP22
Putrescine SCHEMBL867233 0.88 TDP1 (0.67) TDP1LMNAALOX15BLMPMP22
Ethylamine SCHEMBL6856120 0.88
SCHEMBL5708652 0.87 TDP1 (1.00) TDP1LMNAALOX15BLMPMP22
SCHEMBL2128293 0.87 TDP1 (1.00) TDP1LMNAALOX15BLMPMP22
SCHEMBL14870 0.87
SCHEMBL18279809 0.86 TDP1 (0.63) TDP1LMNAALOX15BLMPAOX

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3197940-B1 POLYMERIZABLE POLYSILOXANES WITH HYDROPHILIC SUBSTITUENTS ALCON INC (CH) 2023-02-15 EP disclosed
WO-2022270486-A1 CONTACT LENS AND PRODUCTION METHOD FOR SAID LENS 日油株式会社 2022-12-29 WO disclosed
US-20210161772-A1 RADICAL POLYMERISATION INITIATORS FOR LIGHT-CURABLE DENTAL MATERIALS DENTSPLY SIRONA INC. (US) 2021-06-03 US disclosed
EP-3390497-B1 POLYMERIZABLE POLYSILOXANES WITH HYDROPHILIC SUBSTITUENTS ALCON INC (CH) 2021-01-20 EP disclosed
EP-2931732-B1 AMPHIPHILIC SILOXANE-CONTAINING VINYLIC MONOMERS AND USES THEREOF ALCON INC (CH) 2020-11-25 EP disclosed
EP-3419961-B1 UV/VISIBLE-ABSORBING VINYLIC MONOMERS AND USES THEREOF ALCON INC (CH) 2020-09-02 EP disclosed
EP-3391100-B1 AMPHIPHILIC BRANCHED POLYDIORGANOSILOXANE MACROMERS ALCON INC (CH) 2020-08-12 EP disclosed
US-10676557-B2 Polymerizable polysiloxanes with hydrophilic substituents ALCON INC. (CH) 2020-06-09 US disclosed
US-10597479-B2 Amphiphilic branched polydiorganosiloxane macromers ALCON INC. (CH) 2020-03-24 US disclosed
EP-3532519-A1 AMPHIPHILIC BRANCHED POLYDIORGANOSILOXANE MACROMERS Novartis AG (CH) 2019-09-04 EP disclosed
US-20110196056-A1 RADICAL POLYMERIZATION INHIBITORS FOR LIGHT-CURABLE DENTAL MATERIALS BLACKWELL GORDON 2011-08-11 US disclosed
EP-2291167-A2 RADICAL POLYMERISATION INHIBITORS FOR LIGHT-CURABLE DENTAL MATERIALS Dentsply DeTrey GmbH (DE) 2011-03-09 EP disclosed
EP-2276446-A1 RADICAL POLYMERISATION INITIATORS FOR LIGHT-CURABLE DENTAL MATERIALS Dentsply DeTrey GmbH (DE) 2011-01-26 EP disclosed
WO-2009135677-A1 RADICAL POLYMERISATION INITIATORS FOR LIGHT-CURABLE DENTAL MATERIALS DENTSPLY DETREY GMBH (DE) 2009-11-12 WO disclosed
WO-2009135678-A2 RADICAL POLYMERISATION INHIBITORS FOR LIGHT-CURABLE DENTAL MATERIALS DENTSPLY DETREY GMBH (DE) 2009-11-12 WO disclosed
US-6274687-B1 EMULSION POLYMERIZATION DAISO CO., LTD. (JP) 2001-08-14 US disclosed
US-6046289-A FOR INHIBITING COAGULATION OF BLOOD PLATELETS, INHIBITING ADHESION OF ANIMAL CELLS, OR AS SUBSTRATE FOR CULTURING ANIMAL CELLS FUJIFILM CORPORATION (JP) 2000-04-04 US disclosed
US-5763408-A TUMOR METASTASIS INHIBITORS FUJI PHOTO FILM CO., LTD. (JP) 1998-06-09 US disclosed
EP-0488258-B1 Propenamide derivatives, polymers, copolymers and use thereof FUJI PHOTO FILM CO LTD (JP) 1996-04-17 EP disclosed
EP-0488258-A2 Propenamide derivatives, polymers, copolymers and use thereof FUJI PHOTO FILM CO., LTD. (JP) 1992-06-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110196056-A1 RADICAL POLYMERIZATION INHIBITORS FOR LIGHT-CURABLE DENTAL MATERIALS MAP1LC3A, MAP1LC3B, MAP1LC3C TDP1 1562/4885LMNA 2354/4885ALOX15 1793/4885
US-20210161772-A1 RADICAL POLYMERISATION INITIATORS FOR LIGHT-CURABLE DENTAL MATERIALS DNMT3L, PCMT1, DOT1L TDP1 3618/4885LMNA 945/4885ALOX15 1378/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.